These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20587743)
1. Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients. Riney JN; Hollands JM; Smith JR; Deal EN Ann Pharmacother; 2010; 44(7-8):1141-51. PubMed ID: 20587743 [TBL] [Abstract][Full Text] [Related]
2. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature. Myzienski AE; Lutz MF; Smythe MA Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615 [TBL] [Abstract][Full Text] [Related]
3. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications. Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569 [TBL] [Abstract][Full Text] [Related]
4. Unfractionated heparin infusion for treatment of venous thromboembolism based on actual body weight without dose capping. Shlensky JA; Thurber KM; O'Meara JG; Ou NN; Osborn JL; Dierkhising RA; Mara KC; Bierle DM; Daniels PR Vasc Med; 2020 Feb; 25(1):47-54. PubMed ID: 31623539 [TBL] [Abstract][Full Text] [Related]
5. Use of a modified dosing weight for heparin therapy in a morbidly obese patient. Schwiesow SJ; Wessell AM; Steyer TE Ann Pharmacother; 2005 Apr; 39(4):753-6. PubMed ID: 15741422 [TBL] [Abstract][Full Text] [Related]
6. Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes. Melloni C; Alexander KP; Chen AY; Newby LK; Roe MT; Allen LaPointe NM; Pollack CV; Gibler WB; Ohman EM; Peterson ED; Am Heart J; 2008 Aug; 156(2):209-15. PubMed ID: 18657648 [TBL] [Abstract][Full Text] [Related]
7. Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome. Joncas SX; Poirier P; Ardilouze JL; Carrier N; Fayad T; Farand P Obesity (Silver Spring); 2013 Sep; 21(9):1753-8. PubMed ID: 23404940 [TBL] [Abstract][Full Text] [Related]
8. Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity. Barletta JF; DeYoung JL; McAllen K; Baker R; Pendleton K Surg Obes Relat Dis; 2008; 4(6):748-53. PubMed ID: 18586569 [TBL] [Abstract][Full Text] [Related]
9. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview. Bernardi E; Piccioli A; Oliboni G; Zuin R; Girolami A; Prandoni P Thromb Haemost; 2000 Jul; 84(1):22-6. PubMed ID: 10928464 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients. Marotti SB; Barras M; Kirkpatrick C Ther Drug Monit; 2015 Feb; 37(1):33-9. PubMed ID: 24831654 [TBL] [Abstract][Full Text] [Related]
11. Comment: identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients. Floyd RA Ann Pharmacother; 2010 Dec; 44(12):2037-8; author reply 2038-9. PubMed ID: 21098747 [No Abstract] [Full Text] [Related]
12. Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study. Bauer SR; Ou NN; Dreesman BJ; Armon JJ; Anderson JA; Cha SS; Oyen LJ Mayo Clin Proc; 2009 Dec; 84(12):1073-8. PubMed ID: 19955244 [TBL] [Abstract][Full Text] [Related]
13. In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone. Rosborough TK Pharmacotherapy; 1998; 18(6):1217-23. PubMed ID: 9855319 [TBL] [Abstract][Full Text] [Related]
14. Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory. Moffett BS; Teruya J; Petit C Ann Pharmacother; 2011 Jul; 45(7-8):876-80. PubMed ID: 21775696 [TBL] [Abstract][Full Text] [Related]
15. Unfractionated heparin dosing in obese patients. George C; Barras M; Coombes J; Winckel K Int J Clin Pharm; 2020 Apr; 42(2):462-473. PubMed ID: 32140914 [TBL] [Abstract][Full Text] [Related]
16. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements. White RH; Zhou H; Woo L; Mungall D Arch Intern Med; 1997 Nov; 157(21):2468-72. PubMed ID: 9385298 [TBL] [Abstract][Full Text] [Related]
17. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657 [TBL] [Abstract][Full Text] [Related]
18. Unfractionated heparin dosing for therapeutic anticoagulation in critically ill obese adults. Hohner EM; Kruer RM; Gilmore VT; Streiff M; Gibbs H J Crit Care; 2015 Apr; 30(2):395-9. PubMed ID: 25534987 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of weight-based dosing of unfractionated heparin in obese children. Taylor BN; Bork SJ; Kim S; Moffett BS; Yee DL J Pediatr; 2013 Jul; 163(1):150-3. PubMed ID: 23414664 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of an Unfractionated Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients. Hosch LM; Breedlove EY; Scono LE; Knoderer CA Ann Pharmacother; 2017 Sep; 51(9):768-773. PubMed ID: 28511582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]